Peripheral nerve injury is a debilitating condition. The gold standard for treatment is surgery, requiring an autologous nerve graft. Grafts are harvested from another part of the body (a secondary site) to treat the affected primary area. However, autologous nerve graft harvesting is not without risks, with associated problems including injury to the secondary site. Research into biomaterials has engendered the use of bioartificial nerve conduits as an alternative to autologous nerve grafts. These include synthetic and artificial materials, which can be manufactured into nerve conduits using techniques inspired by nanotechnology. Recent evidence indicates that peptide amphiphiles (PAs) are promising candidates for use as materials for bioengineering nerve conduits. PAs are biocompatible and biodegradable protein-based nanomaterials, capable of self-assembly in aqueous solutions. Their self-assembly system, coupled with their intrinsic capacity for carrying bioactive epitopes for tissue regeneration, form particularly novel attributes for biochemically-engineered materials. Furthermore, PAs can function as biomimetic materials and advanced drug delivery platforms for sustained and controlled release of a plethora of therapeutic agents. Here we review the realm of nerve conduit tissue engineering and the potential for PAs as viable materials in this exciting and rapidly advancing field.
Introduction
Peripheral nerve injury is a critical and disabling condition. Every year, around 100,000 patients in the USA and Europe undergo nerve surgery for the purpose of rectifying it [1] . With a small transection gap of less than 20 mm between nerves, it is possible to surgically repair it by reapproximating the ends of the injured nerve via direct apposition using sutures. However, when lesion gaps are greater than 20 mm, current clinical gold standard dictates the performance of autologous nerve grafting [2] . Nevertheless, there are significant complications associated with this technique. An autologous nerve graft is harvested from another part of the body (the donor site) for use in the lesion (recipient site) in question. This necessitates the generation of a secondary injury at the donor site. Unresolved issues include tissue scarring; insufficient length of nerve graft; formation of neuroma; and the possible loss of sensation and function at the donor site [3] .
To address these disconcerting attributes of autologous nerve grafting, biochemical engineering of nerve conduits has emerged as an alternative technique. A nerve conduit should ideally possess features that permit the regeneration and reanimation of both endogenous and exogenous neural cells [4] (Fig. 1) .
The most important characteristic that a bioartificial nerve conduit must possess is biocompatibility. This means that the material must not be toxic, and its presence in the body should not elicit an immunological response. If the material used is biodegradable, its degradation kinetics should match the rate of nerve tissue regeneration to ensure an optimal healing process. Design parameters should encompass aspects like adequate porosity to facilitate the delivery of nutrients to the regenerating neural cells, and appropriate nanotopography to promote cell adhesion and proliferation [5] . Furthermore, these nerve conduits should also be engineered in such a way that the constituent fibers possess adequate tensile strength without compromising flexibility [6] .
Recent evidence suggests that peptide amphiphiles (PA) are able to fulfill these design criteria, and are emerging as a viable material for bioengineering nerve conduits [7] . PAs have a dual functionality of simultaneously being hydrophobic and hydrophilic, with the additional ability of delivering bioactive molecules to the site of injury [8] . Their supramolecular arrangement allows for the spontaneous selfassembly of nanofibers [9] (Fig. 2) .
This balance of polarity between attractive and repulsive forces within the nano-molecular construct further alludes to their novel properties [10] . In this review, we seek to explore the realm of bioartifical nerve conduit engineering, and expound on the concept of using PAs for the biochemical engineering of nerve conduits.
Biochemical engineering nerve conduits

Overview
Nerve tissue engineering is a rapidly evolving and expanding field in the realm of biomedicine. A multitude of in vitro and in vivo studies have been conducted to assess the viability of different materials, and feasibility of different fabrication methods for building the ideal nerve conduit (Table 1) .
Materials used for manufacturing nerve conduits can be categorized into 2 classes: synthetic [11] and natural [12] . Synthetic materials include aliphatic polyesters, polyurethanes, polyphosphoesters, piezoelectric polymers, and hydrogel-based materials. In contrast, natural materials are derived from animals, with some examples including decellularized scaffolds, polysaccharides (e.g. chitosan), and collagen.
Aliphatic polyesters are a class of polymers, and some examples are: polylactic acid (PLA), polyglycolic acid (PGA) [13, 14] , polycaprolactone (PCL) [15] [16] [17] , poly(3-hydroxybutyrate) (PHB), and poly(lactic-coglycolic acid) (PLGA) [18] [19] [20] . These polymers are biocompatible, and can be synthesized into fibers via a method called electrospinning [21] . Electrospinning is a fabrication technique whereby an electric charge is used to produce exceedingly fine (in the nanoscale) fibers [22] . There is evidence to suggest that neural cells can adhere to and proliferate on these nanofiber assemblies [23] [24] [25] [26] .
Natural materials like laminin [27] , collagen and chitosan [28, 29] have also been investigated as scaffolds for nerve conduits. In addition, semi-natural materials like poly(epsilon-caprolactone)/gelatin and nanofiber-collagen composites have also been explored as possible materials for constructing nerve conduits [30, 31] . These hybrid materials harbor the intrinsic qualities from both natural and synthetic materials [32] [33] [34] .
Design considerations
In addition to selecting the appropriate material, it is imperative to have optimal design parameters that would allow nerve conduits to espouse characteristics of actual nerves. For instance, it is imperative for neural cells in the nerve conduit to obtain nutrients and growth factors [35] (Fig. 3) .
Porosity is one factor that determines the flow of essential growth molecules, and plays an important role for neural and axonal regeneration [36, 37] . Self-assembling peptide nanofibers have been propounded as possible materials for constructing nerve conduits [38, 39] , with several studies indicating their ability to support neural progenitor cell growth and differentiation [40, 41] .
Different nerve conduit materials have been experimented for use in humans (Table 2) , and some examples include expanded polytetrafluoroethylene (ePTFE) [42] [43] [44] [45] , polylactide-caprolactone (PLCL) [46, 47] , polyglycolic acid (PGA) [48] [49] [50] [51] [52] [53] [54] [55] [56] , silicone [57] [58] [59] [60] [61] [62] [63] [64] and collagen [65] [66] [67] [68] [69] . The US Food & Drug Administration (FDA) has approved several nerve conduits for clinical use (Table 3) , and they are generally hollow tubes made from materials like collagen, PGA, PLCL or alcohol-based hydrogels [1, 70, 71] (Fig. 4) .
Peptide amphiphiles
Structure
Peptide amphiphiles (PAs) are self-assembling peptides with the ability to form nanofibers. PAs typically have 4 regions: a hydrophobic alkyl chain, a beta-sheet forming segment, a peptide charged segment, and a customizable bioactive epitope [72] (Fig. 5) . Its capacity for self-assembly can largely be attributed to the balance of attractive and repulsive forces within its nano-architectural arrangement [73] . Evidence indicates that PAs can be used to construct nerve conduits (Table 4) . PAs are biodegradable [74] and does not elicit an appreciable immunological response, underscoring its potential to be a promising material for nerve conduits. Further, the products of degradation are sugars and amino acids, and therefore are not toxic to biological systems. In contrast to PAs, many polymers tend to degrade into products that might not always be biocompatible and can elicit an immune reaction. PAs can also be considered "polymers" of amino acids with charged groups. Hence, the configuration of its nano-architecture can be • Self-assembling peptide nanofiber
Functionalized with motifs from collagen, laminin, fibrin, fibronectin, osteopontin, and osteogenic peptides
In vitro Self-assembly • Scaffolds with bone marrow homing motifs significantly enhanced cell survival • On these scaffolds, the % of cells expressing neuronal markers was similar to that on Matrigel [39] Poly(3-caprolactone) and porcine gelatin blend In vitro ES • Differentiation and proliferation enhanced with respect to PCL nanofibrous scaffolds • Randomly oriented fibers did show good results, but fiber alignment enhanced these effects [30] • Self-assembling peptide nanofiber scaffold • Poly(acrylonitrile-comethylacrylate (PAN-MA) sub-micron aligned fiber films • Films stacked within a hollow polysulfone nerve conduit
In vitro & rats ES
• Aligned constructs promoted axonal regeneration across a 17 mm gap • Recovery of fine motor control was increased with respect to unaligned fibers
• Nanofibrous copolymer of methyl methacrylate and acrylic acid (PMMAAA) Functionalized by immobilization of collagen onto the nanofiber surface
In vitro ES Cell viability assay and metabolic activity assay indicate that this is a suitable material for cell growth.
[31]
• Nanofibrous blend of (C28O4N4H47)n and (C27O4.4N4H50)n Functionalized with tenascin-C derived peptides SD rats ES • Functionalization increased axonal regrowth • Randomly orientated fibers impeded regrowth [22] Murine laminin-1 nanofibrous mesh In vitro ES • Progenitors exhibited neurite growth without addition of growth factors • Rate and quality of attachment was greater than on laminin films
• Poly(L-lactide) (PLLA) nanofibers • Poly(lactide-co-glycolide) (PLGA) nanofibers • Surface treated with KOH to reduce surface tension
In vitro ES
• Both substrates exhibited cellular growth and attachment
• If the inter-fiber distance is greater than 15 μm, the neurons follow the fibers • Neurons travel perpendicular to the fibers at lower inter-fiber distances.
• Neurites did not extend into regions with inter-fiber distances b1 μm • Poly(lactic-co-glycolic acid) (PLGA)and polycaprolactone(PCL) blend • Poly(L-lactide) (PLLA) nanofibers Covalently functionalized with bFGF and laminin
• Synergistic effect of fiber alignment and functionalization • Cell migration higher than in untreated group • Neurite extension was increased with respect to untreated animals [14] Nanofibrous PCL/chitosan blend In vitro ES • Increased cell proliferation and attachment with respect to PCL alone • Schwann cells maintained phenotype after growth on scaffold [32] • 5 different microfibrous scaffold materials
In vitro ES/casting • Cell attachment greatest on the PCL film • Cells were able to penetrate into all nanofibrous scaffolds except PCL [33] (continued on next page) modulated by changes in pH [75] . This therefore highlights the importance of designing the optimal self-assembly configuration of PAs in pH ranges which reflect biological systems [76, 77] .
Nerve regeneration
The nanofiber self-assembly framework of PAs promotes the migration and proliferation of neural cells [78] . Experimental data suggests that the bioactive epitope region of PAs promotes neural cell proliferation [79] [80] [81] . The bioactive epitopes of PAs are customizable to suit different purposes [82, 83] . For instance, integrins would promote adherence of neural cells [84] , while RGD motifs and IKVAV sequences facilitate neural cell growth and proliferation [85] .
IKVAV is a pentapeptide, made up of a sequence of amino acids Ile-Lys-Val-Ala-Val, first identified in the A chain of laminin [86] . IKVAV is a neurite-promoting laminin epitope [87] , and has been demonstrated to upregulate the proliferation of neural cells [88] (Fig. 6 ). In addition, the presence of IKVAV reduces astrocyte formation and hence minimizing the risk of glial scars [89] . Furthermore, it also inhibits apoptosis and mitigates astrogliosis [90] (Fig. 7) . In terms of incorporation of a bioactive epitope on PAs, IKVAV and RGD appear to be the two most widely studied molecules for the application of developing nerve conduits.
Sonic hedgehog homolog (SHH) is a protein that is part of the hedgehog signaling pathway, and is thought to play a vital function in nerve regeneration during injury. Experimental data suggests Hollow tubular conduit
In vivo and in vitro, rats
Glass mold
• 2000 g mol −1 provided best cell attachment and proliferation
• Myelinated nervous tissue was found within the conduit after both 6 and 17 weeks of implantation [17] • Poly(3-hydroxybutyrate)
• Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)
• Microfibrous mats compared to films
In vitro ES
• RT4-D6P2T cell attachment and proliferation were higher on films than fiber mats • L929 attach and proliferate better on fiber mats [24] • Self-assembling RADA16-I peptides • PFSSTKT functional epitope was interspersed within the RADA16-1 fibers • Glycerine spacers were used to separate the RADA16-1 and PFSSTKT within the fiber The no. of spacers was varied from 0 to 4
In vitro Self-assembly Spacers are important in ensuring that the PFSSTKT epitope is exposed to the environment, as opposed to being hidden within molecule [41] • Non-woven chitosan nano/microfiber mesh tubes Introduced glycine spacers into CYIGSR sequence SD rats ES and molding Enhanced nerve regeneration [29] Chitosan non-woven micro/nanofiber mesh tubes SD rats ES and molding Functions as a scaffold for neural cell migration, attachment and nerve regeneration [28] • Chitosan-poly-lactic acid mix • Hollow nerve conduit
SD rats Rotating mandrel
• Material is not cytotoxic in vitro • Chitosan-PLA conduit more effective than silicone conduit at restoring sciatic nerve function [25] Aligned poly(ε-caprolactone) (PCL) nanofibers In vitro ES • Promotes differentiation of cultured embryonic stem cells into neural lineages.
• Aligned fibers direct neurite growth that SHH-incorporated PAs reduce apoptosis and aid nerve regeneration in a cavernous nerve injury rodent model [8] . Furthermore, SHH-incorporated PAs ensure that the bioactive epitope is targeted locally rather than systemically, as activation of the SHH is linked to the progression of cancer.
RGD (Arg-Gly-Asp) is a tripeptide which features prominently in integrins, and is known to mediate peripheral neuron regeneration [91] . Integration of RGD into PAs demonstrated that these bioactive PAs promoted cell proliferation and differentiation. A plethora of peptide sequences can also be incorporated into PAs, making these nanofibers extremely versatile and customizable.
Unlike conventional materials used in nerve tissue engineering, PAs can be directly injected in vivo into models and spontaneously selfassemble into nanofibers in aqueous solutions. Furthermore, PAs can function as biomimetic materials exemplified by collagen-mimetic PAs [92] . Conventional materials often rely on electrospinning as a manufacturing method to achieve fiber-like structures suitable for use in nerve regeneration. The self-assembly nature of PAs allows them to circumvent costly manufacturing methods. However, in contrast to conventional manufacturing methods like electrospinning where quality and batch-to-batch variability can be tightly controlled, merely relying on self-assembly as a method of large-scale commercial production is still an experimental concept. Perhaps the next step would be to carefully compare and contrast the robustness of self-assemled PAs to electrospun nanofibers. Given that the constituent elements in PAs and external factors like pH can affect its structural assembly, parameters must be finely tuned and optimized in order for PA nanofibers to be used as a full-fledged commercialized medical product [93] .
Controlled drug release & delivery
Apart from being purely constructs for nerve regeneration, PAs can also function as efficient drug and gene delivery platforms. Various therapeutic agents can be incorporated into PAs to augment the recovery process and minimize immune response. It has been shown that controlled release of the anti-inflammatory drug dexamethasone can be achieved when incorporated into PAs [94] . The sustained and controlled release of dexamethasone reduced the occurrence of inflammation, thereby speeding up recovery time, which is crucial in regenerative medicine. The application of PAs as gene delivery platforms has also been explored, using antisense oligonucleotide as a payload [95] .
PAs can also function as biomimetic materials, as seen in a study where vascular endothelial growth factor (VEGF)-PAs and basic fibroblast growth factor (bFGF)-PAs were able to enhance bioactivity via direct cell signaling to promote angiogenesis [96, 97] , and was monitored over a month in a sustained release fashion. Along the same lines, heparin (which is prone to enzymatic degradation) was incorporated into PAs to promote angiogenesis and extend its period of bioactivity [98] . As heparin is derived from animals (which harbors a risk of immunogenicity), heparin-mimetic PAs were also developed [69] to circumvent this [99] . This study highlights the potential of delivering molecules with a short half-life or inadequate retention in a sustained and controlled manner using PAs as biomimetic supramolecular structures, which preclude the need of repeated administration or injection.
Interestingly enough, PAs can also be incorporated into liposomes and would function as bioactive ligands for targeted drug delivery [100] (Fig. 8) . This would open up the possibility of PAs having dual functionality of being used as nerve conduits and also drug delivery platforms to treat neoplastic neuromas. Conversely, it has been reported that inclusion of phospholipids into PAs can increase accessibility of the bioactive epitopes, enhancing its drug-releasing or cell-regenerative capacity [101] .
Conclusion and perspectives
The field of bioengineering nerve conduits for regenerative medicine is advancing rapidly [102, 103] . Despite the tremendous amount of research conducted in the search for appropriate materials for nerve conduits, the FDA currently approves only a few materials for that purpose, namely PGA, Type-I collagen, PLCL, and PVA. Furthermore, current materials used in FDA-approved nerve conduits suffer from various limitations. For example, PGA suffers from a high rate of degradation, which would compromise on mechanical properties. Collagen is a natural material, which still poses a risk of immunogenic response, and batch-to-batch variability in terms of the manufacturing process is still a teething problem. The relative rigidity and inflexibility of PLCL necessitate the use of a larger needle during suturing. Lumen blockage and incomplete degradation leading to neuroma formation are also limiting factors for PLCL. PVA is non-biodegradable which harbors a risk of nerve compression, which might have a detrimental effect on the recovery process.
Mounting evidence suggests that PAs can indeed function as viable materials for nerve conduits. The dynamic versatility of PAs being able to harbor bioactive molecules to sustain the growth and development of neurons is a fascinating insight to the realm of regenerative medicine. Indeed, much research has been conducted into elucidating the atomistic molecular dynamics and tunability of PAs and their ability to self-assemble into nano-structures [104] [105] [106] . At present, there are no in vivo studies comparing the use of FDA-approved nerve conduits with PAs. This would undoubtedly be a pertinent starting point to assess the comparative clinical potential for PAs to be used as nerve conduits.
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